Yuyu Pharma Net Asset Quality Index
Yuyu Pharma net asset quality index. Yuyu Pharma (000220) has a Net Asset Quality Index of 68.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩202.42 Billion minus total liabilities of ₩63.32 Billion yields net assets of ₩139.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 000220 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Yuyu Pharma (2011–2024)
Net asset quality index of Yuyu Pharma from 2011 to 2024. This chart shows how Yuyu Pharma's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 68.7%, representing net assets of ₩139.10 Billion against total assets of ₩202.42 Billion KRW. See 000220 total equity for net asset value and shareholders' equity analysis.
Yuyu Pharma Net Asset Quality Index by Year (2011–2024)
Yuyu Pharma net asset quality index by year from 2011 to 2024. The table below presents the year-by-year Net Asset Quality Index for Yuyu Pharma from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Yuyu Pharma market cap and net worth.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 65.0% | ₩135.06 Billion | ₩207.69 Billion | ₩72.62 Billion | ▲ +4.3 pp |
| 2023 | 60.7% | ₩120.36 Billion | ₩198.21 Billion | ₩77.86 Billion | ▼ -2.5 pp |
| 2022 | 63.2% | ₩123.37 Billion | ₩195.21 Billion | ₩71.83 Billion | ▼ -3.5 pp |
| 2021 | 66.7% | ₩128.69 Billion | ₩192.99 Billion | ₩64.30 Billion | ▼ -8.9 pp |
| 2020 | 75.6% | ₩117.04 Billion | ₩154.90 Billion | ₩37.86 Billion | ▲ +9.8 pp |
| 2019 | 65.7% | ₩90.54 Billion | ₩137.72 Billion | ₩47.17 Billion | ▲ +1.5 pp |
| 2018 | 64.2% | ₩86.87 Billion | ₩135.23 Billion | ₩48.35 Billion | ▼ -3.9 pp |
| 2017 | 68.2% | ₩82.83 Billion | ₩121.49 Billion | ₩38.66 Billion | ▼ -2.2 pp |
| 2016 | 70.3% | ₩78.29 Billion | ₩111.30 Billion | ₩33.01 Billion | ▼ -0.3 pp |
| 2015 | 70.7% | ₩73.73 Billion | ₩104.33 Billion | ₩30.60 Billion | ▲ +0.2 pp |
| 2014 | 70.5% | ₩71.49 Billion | ₩101.40 Billion | ₩29.91 Billion | ▼ -4.6 pp |
| 2013 | 75.1% | ₩72.28 Billion | ₩96.26 Billion | ₩23.99 Billion | ▼ -3.3 pp |
| 2012 | 78.4% | ₩69.50 Billion | ₩88.68 Billion | ₩19.18 Billion | ▲ +2.4 pp |
| 2011 | 76.0% | ₩67.23 Billion | ₩88.51 Billion | ₩21.28 Billion | — |